Why the study?
Does the ATP-sensitive potassium channel blocker glyburide abolish the infarct size-reducing effects of ischemic preconditioning or adenosine A1-receptor activation in a canine model of myocardial ischemia?
Does the ATP-sensitive potassium channel blocker glyburide abolish the infarct size-reducing effects of ischemic preconditioning or adenosine A1-receptor activation in a canine model of myocardial ischemia?
In a canine model, the cardioprotective effects of ischemic preconditioning and adenosine A1-receptor activation against myocardial infarction are mediated by ATP-sensitive potassium channels.
Answers are grounded in this paper and cite their sources.
KATP channels mediate preconditioning cardioprotection in canines; leaves open translation to human ischemia management.
BACKGROUND: A brief period of myocardial ischemia can result in an increased resistance to subsequent, more severe episodes of ischemia. Recent studies have indicated that activation of adenosine A1-receptors may mediate this preconditioning effect. It is also known that A1-activation can lead to ATP-sensitive potassium channel (KATP) opening via a G(i) protein-mediated effect. Thus, we determined whether the KATP blocker glyburide could abolish preconditioning or the protective effects of A1-receptor activation. METHODS AND RESULTS: Anesthetized dogs were subjected to 5 minutes of left circumflex coronary artery (LCx) occlusion (or sham) followed by 10 minutes of reperfusion. The hearts were then subjected to 60 minutes of LCx occlusion and 5 hours of reperfusion. Glyburide (5 micrograms/kg/min) or vehicle was given directly into the LCx 20 minutes before preconditioning or sham preconditioning. Preconditioning resulted in a significantly reduced infarct size compared with nonpreconditioned animals. Glyburide abolished the protective effect of preconditioning. To establish a link between KATP and A1-receptor activation, the effect of the A1-agonist R-PIA with or without glyburide on infarct size was determined. R-PIA (0.4 microgram/kg/min, directly into the LCx) significantly reduced infarct size, and this protective effect was abolished by glyburide. None of the treatments described above had a significant effect on peripheral hemodynamic status or myocardial blood flow. CONCLUSIONS: Preconditioning may be mediated by KATP activation, and this may be linked to A1-receptor stimulation.
No takes yet. Share an insight, caveat, or question.
Grover et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: